Doing so much better today! The thickening of my stomach wall is still there, but my fever is gone, and antibiotics seem to be working. I'm all too aware of how many of you have also lived through the "worst days of your lives." I can't stay focused for very long without discomfort. So indulge
Last night's Cure Talks broadcast was both encouraging and overwhelming. Myeloma Institute of Research and Therapy (MIRT) Director, Dr. Gareth Morgan, spent a great deal of time discussing upcoming advances in myeloma therapy and diagnostics. This wasn't more of the same. Dr. Morgan revealed a number of new, innovative approaches being initiated now in Arkansas.
Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 Walter Capone, President of the Multiple Myeloma Research Foundation (MMRF), is excited about a new myeloma therapy: SAR650984. He mentioned this exciting new therapeutic option for heavily pretreated multiple myeloma patients while we were working together in Tampa two weeks ago. Here's the MMRF's press release
I had the good fortune to be asked to speak at a conference about personalized medicine on Saturday. I was part of a panel that included three distinguished researchers with their PhD s: Clement Gwede, Cathy Meade and Gwendolyn Quinn. While you may never have heard of them, you may be familiar with another member
Thursday I ran the first of a three part series about three important cancer research initiatives that the MMRF announced last week. The first initiative hopes to build off momentum from the Multiple Myeloma Research Consortium’s (MMRC) drive to bank tissue from a large subset of multiple myeloma patients, collected in large part by 16